Related references
Note: Only part of the references are listed.Peroxisome Proliferator-Activated Receptor gamma Pathway Targeting in Carcinogenesis: Implications for Chemoprevention
Frank Ondrey
CLINICAL CANCER RESEARCH (2009)
Elevated concentrations of 15-deoxy-Δ12,14-prostaglandin J2 in chronic liver disease propose therapeutic trials with peroxisome proliferator activated receptor γ-inducing drugs
Olav A. Gressner et al.
LIVER INTERNATIONAL (2009)
Peroxisome Proliferator-Activated Receptor γ Overexpression Suppresses Growth and Induces Apoptosis in Human Multiple Myeloma Cells
Tatiana M. Garcia-Bates et al.
CLINICAL CANCER RESEARCH (2008)
Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptorγ ligands in vitro and in vivo
Ming-Chuan Hsu et al.
CLINICAL CANCER RESEARCH (2008)
Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors
Jun Yu et al.
HEPATOLOGY (2008)
The Role of PPAR gamma in Hepatocellular Carcinoma
Ivan Borbath et al.
PPAR RESEARCH (2008)
Regulation of the PTEN promoter by statins and SREBP
Rosemary E. Teresi et al.
HUMAN MOLECULAR GENETICS (2008)
Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer a549 cells
Yi-Lin Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Present concepts and outlook: Function of proliferator-activated receptors (PPARs) for future peroxisome pathogenesis, progression, and therapy of cancer
P. Sertznig et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Underlying mechanisms of pharmacology and toxicity of a novel PPAR agonist revealed using rodent and canine hepatocytes
Yin Guo et al.
TOXICOLOGICAL SCIENCES (2007)
Cdc25 and Wee1: analogous opposites?
Jennifer A. Perry et al.
CELL DIVISION (2007)
Intestinal-specific PPARγ deficiency enhances tumorigenesis in ApcMin/+ mice
Christen A. McAlpine et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
PPARγ insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-κB signaling pathway
Y Kato et al.
ONCOGENE (2006)
Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo
J Yu et al.
HEPATOLOGY (2006)
Peroxisome proliferator-activated receptor-γ ligands suppress fibronectin gene expression in human lung carcinoma cells:: involvement of both CRE and Sp1
SW Han et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
Chemopreventive effect of peroxisome proliferator-activated receptor γ on gastric carcinogenesis in mice
J Lu et al.
CANCER RESEARCH (2005)
Peroxisome proliferator-activated receptor γ inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells
KL Schaefer et al.
CANCER RESEARCH (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
15-Deoxy Delta(12,14)-prostaglandin J(2) suppresses transcription by promoter 3 of the human thromboxane A(2) receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells
AT Coyle et al.
FEBS JOURNAL (2005)
Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells
SJ Baek et al.
CARCINOGENESIS (2004)
Antineoplastic effects of peroxisome proliferator-activated receptor γ agonists
C Grommes et al.
LANCET ONCOLOGY (2004)
Changes in the expression of the peroxisome proliferator-activated receptor γ gene in the colonic polyps and colonic mucosa of acromegalic patients
F Bogazzi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells
H Koga et al.
HEPATOLOGY (2003)
Inhibitory effects of peroxisome proliferator-activated receptor γ on thyroid carcinoma cell growth
ML Martelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1
M Albertoni et al.
ONCOGENE (2002)
Decreased perioxisome proliferator-activated receptor gamma gene expression was correlated with poor prognosis in patients with lung cancer
H Sasaki et al.
LUNG CANCER (2002)
Conditional disruption of the peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux
TE Akiyama et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Proliferation, cell cycle and apoptosis in cancer
GI Evan et al.
NATURE (2001)
Involvement of p21WAF1/Cip1, p27Kip1, and p18INK4c in troglitazone-induced cell-cycle arrest in human hepatoma cell lines
H Koga et al.
HEPATOLOGY (2001)
Share Paper
